UBS AM’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.68M | Buy |
325,645
+45,805
| +16% | +$799K | ﹤0.01% | 1652 |
|
|
2025
Q1 | $3.52M | Buy |
279,840
+32,526
| +13% | +$409K | ﹤0.01% | 1737 |
|
|
2024
Q4 | $2.61M | Buy |
247,314
+12,777
| +5% | +$135K | ﹤0.01% | 1914 |
|
|
2024
Q3 | $3.4M | Buy |
234,537
+207,456
| +766% | +$3.01M | ﹤0.01% | 1771 |
|
|
2024
Q2 | $230K | Buy |
27,081
+14,141
| +109% | +$120K | ﹤0.01% | 2748 |
|
|
2024
Q1 | $132K | Hold |
12,940
| – | – | ﹤0.01% | 2488 |
|
|
2023
Q4 | $70.9K | Hold |
12,940
| – | – | ﹤0.01% | 2533 |
|
|
2023
Q3 | $48.9K | Buy |
+12,940
| New | +$48.9K | ﹤0.01% | 2580 |
|
|
2021
Q1 | – | Sell |
-57,575
| Closed | -$2.67M | – | 2620 |
|
|
2020
Q4 | $2.67M | Buy |
+57,575
| New | +$2.67M | ﹤0.01% | 1566 |
|